David Iglesias, MD - Research

Research at a glance

Top areas of exploration

Endometrial Neoplasms , 9 publications
Metformin , 5 publications
Uterine Neoplasms , 4 publications
Carcinoma, Endometrioid , 4 publications

Research activity

24 publications

934 citations

Why is this important?

Active clinical trials

Comparing Two Surgical Procedures in Individuals with Ovarian Cancer+BRCA1 Mutations(SOROCk)

This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the鈥�

Investigator: David Iglesias
Status: Accepting Candidates
Ages: 35 Years - 50 Years
Sexes: Female

My publications

24 publications

2017

Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTEN.

Oncology

鈥�

2016

Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.

Gynecologic oncology

鈥�

2014

Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53.

Cancer

鈥�

2014

Pelvic exenteration: impact of age on surgical and oncologic outcomes.

Gynecologic oncology

鈥�

2014

The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

鈥�

网红黑料

David Iglesias, MD : Research

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTEN.

Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.

Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53.

Pelvic exenteration: impact of age on surgical and oncologic outcomes.

The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer.

网红黑料

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Filter publications

Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTEN.

Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study.

Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53.

Pelvic exenteration: impact of age on surgical and oncologic outcomes.

The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer.